(Q81042764)

English

Optimal scheduling to reduce morbidity of involved field radiotherapy with transplantation for lymphomas: a prospective Australasian Leukaemia and Lymphoma Group Study

scientific article published on 01 February 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15558040%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Optimal scheduling to reduce morbidity of involved field radiotherapy with transplantation for lymphomas: a prospective Australasian Leukaemia and Lymphoma Group Study (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15558040%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15558040%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

author name string

A Wirth

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15558040%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

H M Prince

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15558040%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

M Wolf

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15558040%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

J M Stone

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15558040%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

J Matthews

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15558040%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

J Gibson

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15558040%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

C Macleod

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15558040%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

A Grigg

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15558040%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

B To

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15558040%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

D Roos

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15558040%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

A P Schwarer

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15558040%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

S Davis

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15558040%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Australasian Leukaemia and Lymphoma Group

14

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15558040%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

publication date

1 February 2005

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15558040%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Bone Marrow Transplantation

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15558040%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

35

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15558040%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15558040%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

291-298

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15558040%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

https://scigraph.springernature.com/pub.10.1038/sj.bmt.1704759

0 references

Bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704759

7 January 2021

based on heuristic

inferred from DOI database lookup

Should involved-field radiation therapy be used as an adjunct to lymphoma autotransplantation?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704759

7 January 2021

based on heuristic

inferred from DOI database lookup

Patterns of failure following high-dose chemotherapy and autologous bone marrow transplantation with involved field radiotherapy for relapsed/refractory Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704759

7 January 2021

based on heuristic

inferred from DOI database lookup

One hundred autotransplants for relapsed or refractory Hodgkin's disease and lymphoma: value of pretransplant disease status for predicting outcome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704759

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose etoposide and melphalan, and autologous bone marrow transplantation for patients with advanced Hodgkin's disease: importance of disease status at transplant

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704759

7 January 2021

based on heuristic

inferred from DOI database lookup

Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704759

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose therapy and autologous bone marrow transplantation for relapsed/refractory Hodgkin's disease: the impact of involved field radiotherapy on patterns of failure and survival

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704759

7 January 2021

based on heuristic

inferred from DOI database lookup

Autologous stem-cell transplantation for non-Hodgkin's lymphomas: the role of graft purging and radiotherapy posttransplantation--results of a retrospective analysis on 120 patients autografted in a single institution.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704759

7 January 2021

based on heuristic

inferred from DOI database lookup

Autotransplantation for relapsed or refractory Hodgkin's disease: long-term follow-up and analysis of prognostic factors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704759

7 January 2021

based on heuristic

inferred from DOI database lookup

Autologous transplantation for diffuse aggressive non-Hodgkin's lymphoma in patients never achieving remission: a report from the Autologous Blood and Marrow Transplant Registry

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704759

7 January 2021

based on heuristic

inferred from DOI database lookup

The impact of external beam radiation therapy prior to autologous bone marrow transplantation in patients with non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704759

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose cyclophosphamide, carmustine, and etoposide followed by autologous bone marrow transplantation in patients with lymphoid malignancies who have received dose-limiting radiation therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704759

7 January 2021

based on heuristic

inferred from DOI database lookup

Accelerated hyperfractionated total-lymphoid irradiation, high-dose chemotherapy, and autologous bone marrow transplantation for refractory and relapsing patients with Hodgkin's disease.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704759

7 January 2021

based on heuristic

inferred from DOI database lookup

Involved field radiation therapy for Hodgkin's disease autologous bone marrow transplantation regimens

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704759

7 January 2021

based on heuristic

inferred from DOI database lookup

Intensive chemotherapy with cyclophosphamide, carmustine, and etoposide followed by autologous bone marrow transplantation for relapsed Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704759

7 January 2021

based on heuristic

inferred from DOI database lookup

Haematological toxicity of radiotherapy following high-dose chemotherapy and autologous bone marrow transplantation in patients with recurrent Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704759

7 January 2021

based on heuristic

inferred from DOI database lookup

Integrating radiotherapy into bone marrow transplantation programs for Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704759

7 January 2021

based on heuristic

inferred from DOI database lookup

High-Dose Chemotherapy and Radiotherapy With Bone Marrow Transplantation in the Management of the Non-Hodgkin's Lymphomas

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704759

7 January 2021

based on heuristic

inferred from DOI database lookup

Radiation therapy as a component of high-dose salvage strategies in Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704759

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose therapy and autologous bone marrow transplantation after failure of conventional chemotherapy in adults with intermediate-grade or high-grade non-Hodgkin's lymphoma.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704759

7 January 2021

based on heuristic

inferred from DOI database lookup

Autologous bone marrow transplantation in B-cell non-Hodgkin's lymphoma: very low treatment-related mortality in 100 patients in sensitive relapse

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704759

7 January 2021

based on heuristic

inferred from DOI database lookup

Autologous marrow transplantation for malignant lymphoma: a report of 101 cases from Seattle

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704759

7 January 2021

based on heuristic

inferred from DOI database lookup

Patterns of outcome following recurrence after myeloablative therapy with autologous bone marrow transplantation for follicular lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704759

7 January 2021

based on heuristic

inferred from DOI database lookup

Radiotherapy with curative intent: an option in selected patients relapsing after chemotherapy for advanced Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704759

7 January 2021

based on heuristic

inferred from DOI database lookup

Radiotherapy as salvage treatment in patients with Hodgkin's disease or non-Hodgkin's lymphoma relapsing after initial chemotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704759

7 January 2021

based on heuristic

inferred from DOI database lookup

Salvage radiotherapy in recurrent Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704759

7 January 2021

based on heuristic

inferred from DOI database lookup

Radiation therapy salvage of Hodgkin's disease following chemotherapy failure

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704759

7 January 2021

based on heuristic

inferred from DOI database lookup

Wide-field radiation therapy with or without chemotherapy for patients with Hodgkin disease in relapse after initial combination chemotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704759

7 January 2021

based on heuristic

inferred from DOI database lookup

Radical radiotherapy as salvage treatment for relapse of Hodgkin's disease initially treated by chemotherapy alone: prognostic significance of the disease-free interval.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704759

7 January 2021

based on heuristic

inferred from DOI database lookup

The effectiveness of radiotherapy for localized relapse in patients with Hodgkin's disease (IIB-IVB) who obtained a complete response with chemotherapy alone as initial treatment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704759

7 January 2021

based on heuristic

inferred from DOI database lookup

Salvage radiotherapy following chemotherapy failure in Hodgkin's disease--what is its role?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704759

7 January 2021

based on heuristic

inferred from DOI database lookup

Salvage radiotherapy for Hodgkin's disease following chemotherapy failure

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704759

7 January 2021

based on heuristic

inferred from DOI database lookup

Involved field radiation post autologous stem cell transplantation in lymphoma patients is associated with major haematological toxicities

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704759

7 January 2021

based on heuristic

inferred from DOI database lookup

Hodgkin and non-Hodgkin lymphoma: local-regional radiation therapy after bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704759

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized study to evaluate the use of high-dose therapy as part of primary treatment for "aggressive" lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704759

7 January 2021

based on heuristic

inferred from DOI database lookup

Thoracic radiation therapy before autologous bone marrow transplantation in relapsed or refractory Hodgkin's disease. PMH Lymphoma Group, and the Toronto Autologous BMT Group.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704759

7 January 2021

based on heuristic

inferred from DOI database lookup

Improved survival of poor prognosis diffuse histiocytic (large cell) lymphoma managed with sequential induction chemotherapy, "boost" radiation therapy, and autologous bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704759

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase I study of involved-field radiotherapy preceding autologous stem cell transplantation for patients with high-risk lymphoma or Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704759

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of cancer chemotherapeutic drugs on radiation-induced lung damage in mice.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704759

7 January 2021

based on heuristic

inferred from DOI database lookup

Cyclophosphamide 24 hours before or after total body irradiation: effects on lung and bone marrow

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704759

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of radiotherapy and chemotherapy on pulmonary function after treatment for breast cancer and lymphoma: A follow-up study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704759

7 January 2021

based on heuristic

inferred from DOI database lookup

Autologous stem-cell transplantation for Hodgkin's disease: results and prognostic factors in 494 patients from the Grupo Español de Linfomas/Transplante Autólogo de Médula Osea Spanish Cooperative Group.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704759

7 January 2021

based on heuristic

inferred from DOI database lookup

Radiation myelopathy following transplantation and radiotherapy for non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704759

7 January 2021

based on heuristic

inferred from DOI database lookup

A re-analysis of available dose-response and time-dose data in Hodgkin's disease.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704759

7 January 2021

based on heuristic

inferred from DOI database lookup

Dose-response analysis for radiotherapy delivered to patients with intermediate-grade and large-cell immunoblastic lymphomas that have completely responded to CHOP-based induction chemotherapy.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704759

7 January 2021

based on heuristic

inferred from DOI database lookup

Radiation therapy after a partial response to CHOP chemotherapy for aggressive lymphomas

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704759

7 January 2021

based on heuristic

inferred from DOI database lookup

What is the optimal treatment volume in Hodgkin's disease patients undergoing high-dose chemotherapy and adjuvant radiation therapy?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704759

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q81042764&oldid=1764647037"